EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

Martin Metzenmacher, Frank Griesinger, Horst-Dieter Hummel, Corinna Elender, Harald Schäfer, Maike de Wit, Ulrich Kaiser, Jens Kern, Martina Jänicke, Lisa Spring, Stefan Zacharias, Anja Kaiser-Osterhues und 11 weitere

European Respiratory Journal · 2023-02 · 61 (2) · 2201336

DOI: 10.1183/13993003.01336-2022 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Respiratory Journal, online erschienen am 30.09.2022. Verfasst von Martin Metzenmacher und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novartis, Takeda Pharmaceutical Company, Bristol-Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Understanding prognosis, especially long-term outcome, in advanced nonsmall cell lung cancer (NSCLC) is crucial to inform patients, guide treatment and plan supportive and palliative care.

Methods

Prognostic factors influencing overall survival (OS) and progression-free survival (PFS) in 2082 patients with wild-type (WT)-NSCLC (629 M1a, 249 M1b, 1204 M1c) are reported. Patients were included in the prospective German CRISP registry recruiting in >150 centres. Analysis for pre-therapeutic factors was based on results from Cox proportional hazard models.

Results

Current M-descriptors of the Union for International Cancer Control-8 staging system were validated: M1a and M1b patients had significantly longer median time to events compared to M1c (OS/PFS 16.4/7.2 months, 17.8/6.7 months and 10.9/5.4 months, respectively). OS and PFS were influenced by number and location of metastatic organ systems. M1c and four or more metastatic organs involved had shorter OS and PFS than M1c with one to three organs (OS hazard ratio (HR) 1.69, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsFemaleHumansMaleNeoplasm StagingPrognosisProspective StudiesRetrospective StudiesRisk Factors

Autor:innen und Institutionen

  • Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, Essen, Germany.
  • Department of Haematology and Oncology, University Dept Internal Medicine-Oncology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.
  • Interdisziplinäres Studienzentrum mit ECTU/Translationale Onkologie, Comprehensive Cancer Center, Mainfranken, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Pneumologie, Infektiologie, Internistische Intensivmedizin, Klinik Nord im Klinikum Dortmund, Dortmund, Germany.
  • Pneumologie, Thorakale Onkologie, Palliativmedizin, Infektiologie, SHG Kliniken Völklingen, Völklingen, Germany.

Förderung

  • Novartis
  • Takeda Pharmaceutical Company
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Merck Sharp and Dohme
  • Roche
  • Janssen-Cilag
  • AstraZeneca

Zitieren

APA

Metzenmacher, M., Griesinger, F., Hummel, H. D., Elender, C., Schäfer, H., de Wit, M., Kaiser, U., Kern, J., Jänicke, M., Spring, L., Zacharias, S., Kaiser-Osterhues, A., Groth, A., Hipper, A., Zaun, G., Dörfel, S., Güldenzoph, B., Müller, L., Uhlig, J., …, & CRISP Registry Group (2023). Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry. European Respiratory Journal, 61(2), 2201336. https://doi.org/10.1183/13993003.01336-2022

Vancouver

Metzenmacher M, Griesinger F, Hummel HD, Elender C, Schäfer H, de Wit M, et al. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry. European Respiratory Journal. 2023;61(2):2201336. doi:10.1183/13993003.01336-2022

BibTeX
@article{Metzenmacher2023,
  author = {Metzenmacher, Martin and Griesinger, Frank and Hummel, Horst-Dieter and Elender, Corinna and Schäfer, Harald and de Wit, Maike and Kaiser, Ulrich and Kern, Jens and Jänicke, Martina and Spring, Lisa and Zacharias, Stefan and Kaiser-Osterhues, Anja and Groth, Annika and Hipper, Annette and Zaun, Gregor and Dörfel, Steffen and Güldenzoph, Björn and Müller, Lothar and Uhlig, Jens and Thomas, Michael and Sebastian, Martin and Eberhardt, Wilfried E E and CRISP Registry Group, CRISP Registry Group},
  title = {Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry},
  journal = {European Respiratory Journal},
  year = {2023},
  volume = {61},
  number = {2},
  pages = {2201336},
  doi = {10.1183/13993003.01336-2022}
}
Kostenlos starten →